NCT07045571View on ClinicalTrials.gov

MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 30, 2022

Primary Completion Date

January 22, 2026

Study Completion Date

July 22, 2026

Conditions
Pancreatic NeoplasmPancreas Cancer
Trial Locations (1)

Unknown

RECRUITING

Renji hospital, Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
collaborator

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Ruijin Hospital

OTHER

collaborator

Changhai Hospital

OTHER

lead

Yingbin Liu, MD, PhD, FACS

OTHER